Abola, P. and Jabishvili, G. (2025) “Incidence of adverse and safety events in individuals with Parkinson’s disease treated with catechol-o-methyltransferase inhibitor opicapone as an add-on to levodopa treatment: a systematic review and meta-analysis”, Prospects in Pharmaceutical Sciences, 23(4), pp. 175–185. doi: 10.56782/pps.563.